Peptide-based allosteric inhibitor targets TNFR1 conformationally active region and disables receptor-ligand signaling complex.

Autor: Jialiu Zeng, Gavin Wen Zhao Loi, Saipuljumri, Eka Norfaishanty, Romero Durán, Marco Antonio, Silva-García, Octavio, Perez-Aguilar, Jose Manuel, Baizabal-Aguirre, Víctor M., Chih Hung Lo

Publikováno v: Proceedings of the National Academy of Sciences of the United States of America; 4/2/2024, Vol. 121 Issue 14, p1-12, 28p